• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Compliance with depot antipsychotic medication by patients attending outpatient clinics.

作者信息

Heyscue B E, Levin G M, Merrick J P

机构信息

Massachusetts College of Pharmacy and Allied Health Sciences in Boston, USA.

出版信息

Psychiatr Serv. 1998 Sep;49(9):1232-4. doi: 10.1176/ps.49.9.1232.

DOI:10.1176/ps.49.9.1232
PMID:9735970
Abstract

Outpatients with schizophrenia often have problems complying with a regimen of oral antipsychotic medications. Use of depot medications improves compliance, but patients' geographic location and access to transportation may affect compliance with a depot regimen. The authors used retrospective chart review to examine whether patients' geographic location and sociodemographic characteristics and characteristics of their medication use were related to compliance with a depot regimen. The subjects were 75 patients attending an urban clinic and 23 patients attending a rural clinic in New York State. Median rates of compliance were 94.7 percent for the urban patients and 96.4 percent for the rural patients, not a significant difference. The only characteristic associated with a decreased compliance rate was a history of substance abuse.

摘要

相似文献

1
Compliance with depot antipsychotic medication by patients attending outpatient clinics.
Psychiatr Serv. 1998 Sep;49(9):1232-4. doi: 10.1176/ps.49.9.1232.
2
Postdischarge medication compliance of inpatients converted from an oral to a depot neuroleptic regimen.从口服抗精神病药物治疗方案转换为长效抗精神病药物治疗方案的住院患者出院后用药依从性。
Psychiatr Serv. 1995 Oct;46(10):1049-54. doi: 10.1176/ps.46.10.1049.
3
Problems of compliance in the outpatient treatment of schizophrenia.精神分裂症门诊治疗中的依从性问题。
J Clin Psychiatry. 1983 Jun;44(6 Pt 2):3-6.
4
Impact of splitting risperidone tablets on medication adherence and on clinical outcomes for patients with schizophrenia.利培酮片掰开服用对精神分裂症患者药物依从性及临床结局的影响。
Psychiatr Serv. 2007 Feb;58(2):201-6. doi: 10.1176/ps.2007.58.2.201.
5
Community treatment orders: relationship to clinical care, medication compliance, behavioural disturbance and readmission.社区治疗令:与临床护理、药物依从性、行为障碍及再入院的关系
Aust N Z J Psychiatry. 2000 Oct;34(5):801-8. doi: 10.1080/j.1440-1614.2000.00813.x.
6
Changes in adherence and treatment costs following initiation of oral or depot typical antipsychotics among previously non-adherent patients with schizophrenia.先前未坚持服药的精神分裂症患者开始使用口服或长效典型抗精神病药物后依从性和治疗成本的变化。
Hum Psychopharmacol. 2013 Sep;28(5):438-46. doi: 10.1002/hup.2328. Epub 2013 Jun 15.
7
Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight.精神分裂症门诊患者对抗精神病药物的依从性;与对抗精神病药物的主观反应的关系;对药物治疗的态度及自知力
Compr Psychiatry. 1998 Jul-Aug;39(4):215-9. doi: 10.1016/s0010-440x(98)90063-3.
8
Predictors for starting depot administration of risperidone in chronic users of antipsychotics.抗精神病药物长期使用者开始使用利培酮长效注射剂的预测因素。
J Clin Psychopharmacol. 2008 Dec;28(6):625-30. doi: 10.1097/JCP.0b013e31818a6d10.
9
Community treatment orders and antipsychotic long-acting injections.社区治疗令与抗精神病长效注射剂
Br J Psychiatry Suppl. 2009 Nov;52:S57-62. doi: 10.1192/bjp.195.52.s57.
10
A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients.“旋转门”型精神分裂症患者门诊抗精神病药物治疗的药物经济学模型
J Clin Psychiatry. 1996 Aug;57(8):337-45.

引用本文的文献

1
Medication adherence in schizophrenia.精神分裂症患者的药物依从性。
World J Psychiatry. 2012 Oct 22;2(5):74-82. doi: 10.5498/wjp.v2.i5.74.
2
Patients' and clinicians' attitude towards long-acting depot antipsychotics in subjects with a first episode of psychosis.首发精神病患者长效 depot 抗精神病药治疗的患者和临床医生的态度。
Ther Adv Psychopharmacol. 2013 Apr;3(2):89-99. doi: 10.1177/2045125312464106.
3
Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations.
长效抗精神病药物治疗精神分裂症:来自自然观察的日常实践应用。
BMC Psychiatry. 2012 Aug 21;12:122. doi: 10.1186/1471-244X-12-122.
4
Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian population.埃塞俄比亚人群中治疗精神病药物的依从性:发生率及危险因素
BMC Clin Pharmacol. 2012 Jun 18;12:10. doi: 10.1186/1472-6904-12-10.
5
Use of risperidone long-acting injectable in a rural border community clinic in southern california.利培酮长效注射剂在南加州一个农村边境社区诊所的使用。
Psychiatry (Edgmont). 2008 Jun;5(6):43-9.
6
Tactics and technologies to manage nonadherence in patients with schizophrenia.管理精神分裂症患者不依从性的策略与技术
Curr Psychiatry Rep. 2008 Aug;10(4):359-69. doi: 10.1007/s11920-008-0057-7.
7
The prediction of mental health service use in residential care.住宿护理机构中精神卫生服务利用情况的预测
Community Ment Health J. 2001 Aug;37(4):313-22. doi: 10.1023/a:1017548507608.
8
Determinants of anti-psychotic medication compliance in a multicultural population.多元文化人群中抗精神病药物依从性的决定因素
Community Ment Health J. 2001 Jun;37(3):273-83. doi: 10.1023/a:1017585231773.
9
Patient compliance with drug therapy in schizophrenia. Economic and clinical issues.精神分裂症患者对药物治疗的依从性。经济和临床问题。
Pharmacoeconomics. 2000 Aug;18(2):106-24. doi: 10.2165/00019053-200018020-00002.